Showing results (261-270 of 9,852) with videos related to
Sort By:
Pageof 986
Arzneimittel-Forschung|January 1, 1978
[Muscle metabolic state in tourniquet syndrome in the rat after administration of the proteinase inhibitor aprotinin (author's transl)]H Molzberger, E Heugel, W IsselhardArzneimittel-Forschung|January 1, 1975
Pharmacological properties of 2-(2-chloro-p-toluidino)-2-imidazoline-nitrate (tolonidine), a new antihypertensive agent. III. Action on the secretions of the digestive tract and on the central nervous system, acute toxicityD Cosnier, J Hache, C Labrid, et al.Arzneimittel-Forschung|July 1, 1988
Reversible prevention of platelet activation by (E,Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxide (ajoene) in dogs under extracorporeal circulationR Apitz-Castro, E Ledezma, J Escalante, et al.Arzneimittel-Forschung|July 1, 1988
Effects of bezafibrate and gemfibrozil on serum lipoproteins in primary hypercholesterolemiaP WeisweilerArzneimittel-Forschung|October 1, 1988
Drug-protein interactions. On the protein-protein interaction induced by levamisole in vitro. A mechanism hypothesisM Chicault, C Luu Duc, A BoucherleArzneimittel-Forschung|October 1, 1988
Comparison of the metabolism and pharmacokinetics of metbufen and itanoxone and their analogues in ratsJ L Chanal, M Audran, M C Bret, et al.Arzneimittel-Forschung|October 1, 1988
Influence of shape stabilizing agents on the deformability and morphology of lysolecithin-treated erythrocytesH RogauschArzneimittel-Forschung|October 1, 1988
Pharmacokinetic study of 14C-radiolabelled elliptinium acetate in patients with metastatic breast cancerM Maftouh, C Picard, H RochéArzneimittel-Forschung|October 1, 1988
Pharmacokinetics and biodisposition of recombinant human interferon-alpha 2C in rat and marmosetA Greischel, P Tanswell, U Busch, et al.Arzneimittel-Forschung|August 1, 1988
Safety and toxicological profile of the new antitussive levodropropizineA Bestetti, P Giuliani, A Nunziata, et al.Pageof 986